home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Scorpion Therapeutics to Present Mutant-Selective PI3Kα Program at AACR Annual Meeting 2022
Scorpion Therapeutics to Present Mutant-Selective PI3Kα Program at AACR Annual Meeting 2022
Post navigation
Previous Post
Previous
Boundless Bio to Present at the Oppenheimer 32nd Annual Healthcare Conference
Next Post
Next
Blueprint Medicines to Showcase Broad Precision Therapy Pipeline at AACR Annual Meeting 2022